These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6133201

  • 1. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Bhargava HN, Pandey RN, Matwyshyn GA.
    Life Sci; 1983 May 02; 32(18):2096-101. PubMed ID: 6133201
    [Abstract] [Full Text] [Related]

  • 2. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C, Yaksh TL.
    J Pharmacol Exp Ther; 1984 Jan 02; 228(1):1-12. PubMed ID: 6319664
    [Abstract] [Full Text] [Related]

  • 3. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM, White TD, Sawynok J.
    J Pharmacol Exp Ther; 1995 Oct 02; 275(1):84-93. PubMed ID: 7562600
    [Abstract] [Full Text] [Related]

  • 4. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep 02; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 5. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):103-7. PubMed ID: 16445907
    [Abstract] [Full Text] [Related]

  • 6. A multiplicity of opiate receptors and enkephalin neuronal systems.
    Snyder SH.
    J Clin Psychiatry; 1982 Jun 15; 43(6 Pt 2):9-12. PubMed ID: 6282818
    [Abstract] [Full Text] [Related]

  • 7. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA, Ferrer-Alcón M, Martín M, Kieffer BL, Maldonado R.
    Neuropharmacology; 2004 Mar 15; 46(4):519-30. PubMed ID: 14975676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1996 Oct 15; 279(1):39-46. PubMed ID: 8858973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats.
    Xie YF, Wang J, Huo FQ, Jia H, Tang JS.
    Neuroscience; 2004 Oct 15; 126(3):717-26. PubMed ID: 15183520
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A, Sorrentino L.
    Br J Pharmacol; 1997 Mar 15; 120(6):1001-6. PubMed ID: 9134209
    [Abstract] [Full Text] [Related]

  • 16. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF, Goldstein A.
    Mol Pharmacol; 1984 May 15; 25(3):337-42. PubMed ID: 6328259
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL.
    J Pharmacol Exp Ther; 1994 Sep 15; 270(3):1086-96. PubMed ID: 7932156
    [Abstract] [Full Text] [Related]

  • 18. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 15; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 19. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 15; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I, Napier TC.
    J Pharmacol Exp Ther; 1995 Mar 15; 272(3):1260-70. PubMed ID: 7891342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.